New advancements to robotic surgery systems are changing how doctors perform procedures and how quickly patients recover.

Pivotal trial will assess ability of abenacianine to reveal malignant tissue during minimally invasive and robotic surgical proceduresMINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.